10-Q Filing

Silo Pharma, Inc. CIK: 1514183 Q2 2013

Filing Information

Form Type	10-Q
Accession Number	`0001213900-13-004042`
Period End Date	20130630
Filing Date	20130808
Fiscal Year	2013
Fiscal Period	Q2
XBRL Instance	gldsw-20130630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 50 Income Statement 23 Cash Flow Statement 47 Stockholders Equity 25

Balance Sheet 50 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash	`Cash`	$368.68K	USD	Point-in-time
Cash	`Cash`	$279.00	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	4,000.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$279.00	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$368.68K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	4,000.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total Assets	`Assets`	$279.00	USD	Point-in-time
Total Assets	`Assets`	$368.68K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.73M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.63M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$13.88K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$20.69K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.63M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.73M	shares	Point-in-time
Notes payable	`NotesPayableCurrent`	$20.00K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$5.00K	USD	Point-in-time
Interest payable	`InterestPayableCurrent`	$1.35K	USD	Point-in-time
Interest payable	`InterestPayableCurrent`	-	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$35.23K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$25.69K	USD	Point-in-time
Notes payable	`LongTermNotesPayable`	$15.00K	USD	Point-in-time
Interest payable	`InterestPayableCurrentAndNoncurrent`	$782.00	USD	Point-in-time
Total Long Term Liabilities	`LiabilitiesNoncurrent`	-	USD	Point-in-time
Total Long Term Liabilities	`LiabilitiesNoncurrent`	$15.78K	USD	Point-in-time
Total Liabilities	`Liabilities`	$41.47K	USD	Point-in-time
Total Liabilities	`Liabilities`	$35.23K	USD	Point-in-time
Series A, Convertible Preferred stock, $0.0001 par value, 5,000,000 shares authorized; 4,000 and none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Series A, Convertible Preferred stock, $0.0001 par value, 5,000,000 shares authorized; 4,000 and none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 30,731,200 and 30,631,200 shares issued and outstanding	`CommonStockValue`	$3.06K	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 30,731,200 and 30,631,200 shares issued and outstanding	`CommonStockValue`	$3.07K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.12M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.54M	USD	Point-in-time
Equity accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$1.21M	USD	Point-in-time
Equity accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$1.17M	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$-41.19K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$-1.75K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$333.45K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$47.48K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$368.68K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$279.00	USD	Point-in-time

Income Statement 23 line items

Line Item	Tag	Value	Unit	Period
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.21M	USD	12 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$45.36K	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$18.71K	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$22.48K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$5.67K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.48K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-49.80K	USD	Annual
Net loss	`NetIncomeLoss`	$-1.08M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-18.71K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-5.67K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.45K	USD	Annual
Net loss	`NetIncomeLoss`	$-45.36K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.21M	USD	12 Qtrs
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	12 Qtrs
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	2 Qtrs
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	2 Qtrs
Weighted average number of common shares outstanding during the period - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.63M	shares	1 Quarter
Weighted average number of common shares outstanding during the period - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.68M	shares	2 Qtrs
Weighted average number of common shares outstanding during the period - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.73M	shares	1 Quarter
Weighted average number of common shares outstanding during the period - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.49M	shares	12 Qtrs
Weighted average number of common shares outstanding during the period - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.63M	shares	2 Qtrs

Cash Flow Statement 47 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-22.48K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-49.80K	USD	Annual
Net loss	`NetIncomeLoss`	$-1.08M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-18.71K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-5.67K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.45K	USD	Annual
Net loss	`NetIncomeLoss`	$-45.36K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.21M	USD	12 Qtrs
Stock issued for services - related parties	`ShareBasedCompensation`	-	USD	2 Qtrs
Stock issued for services - related parties	`ShareBasedCompensation`	-	USD	2 Qtrs
Stock issued for services - related parties	`ShareBasedCompensation`	$1.07M	USD	12 Qtrs
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-6.24K	USD	2 Qtrs
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$15.23K	USD	12 Qtrs
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$2.77K	USD	2 Qtrs
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-51.60K	USD	2 Qtrs
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-122.88K	USD	12 Qtrs
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-15.94K	USD	2 Qtrs
Proceeds from notes payable	`ProceedsFromNotesPayable`	-	USD	2 Qtrs
Proceeds from notes payable	`ProceedsFromNotesPayable`	$20.00K	USD	12 Qtrs
Proceeds from notes payable	`ProceedsFromNotesPayable`	$15.00K	USD	2 Qtrs
Proceeds from issuance of Series A, Convertible Preferred Stock	`ProceedsFromIssuanceOfConvertiblePreferredStock`	$400.00K	USD	2 Qtrs
Proceeds from issuance of Series A, Convertible Preferred Stock	`ProceedsFromIssuanceOfConvertiblePreferredStock`	$400.00K	USD	12 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$71.56K	USD	12 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$20.00K	USD	2 Qtrs
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$420.00K	USD	2 Qtrs
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$491.56K	USD	12 Qtrs
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$15.00K	USD	2 Qtrs
Net Increase (Decrease) in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$368.68K	USD	12 Qtrs
Net Increase (Decrease) in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$368.40K	USD	2 Qtrs
Net Increase (Decrease) in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-939.00	USD	2 Qtrs
Cash - Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$279.00	USD	Point-in-time
Cash - Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$368.68K	USD	Point-in-time
Cash - Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$813.00	USD	Point-in-time
Cash - Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$1.75K	USD	Point-in-time
Cash - Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash - End of Period	`CashAndCashEquivalentsAtCarryingValue`	$279.00	USD	Point-in-time
Cash - End of Period	`CashAndCashEquivalentsAtCarryingValue`	$368.68K	USD	Point-in-time
Cash - End of Period	`CashAndCashEquivalentsAtCarryingValue`	$813.00	USD	Point-in-time
Cash - End of Period	`CashAndCashEquivalentsAtCarryingValue`	$1.75K	USD	Point-in-time
Cash - End of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Income Taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Income Taxes	`IncomeTaxesPaid`	-	USD	12 Qtrs
Income Taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Interest	`InterestPaid`	-	USD	2 Qtrs
Interest	`InterestPaid`	-	USD	2 Qtrs
Interest	`InterestPaid`	-	USD	12 Qtrs

Stockholders Equity 25 line items

Line Item	Tag	Value	Unit	Period
Stock issued for services - related parties, Value per share	`StockIssuedForServicesRelatedPartiesFairMarketValue`	$0.05	USD	2 Qtrs
Stock issued for cash, Value per share	`StockIssuedForCashFairMarketValue`	$0.20	USD	2 Qtrs
Stock issued for cash, Minimum fair market value	`StockIssuedForCashMinimumFairMarketValue`	$0.01	USD	2 Qtrs
Stock issued for cash, Maximum fair market value	`StockIssuedForCashMaximumFairMarketValue`	$0.05	USD	2 Qtrs
Preferred stock issued for cash, Value per share	`PreferredStockIssuedForCashFairMarketValue`	$100.00	USD	2 Qtrs
Beginning balance	`StockholdersEquity`	$-41.19K	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$-1.75K	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$333.45K	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$47.48K	USD	Point-in-time
Preferred stock issued for cash ($100/Share)	`PreferredStockIssuedDuringPeriodValueIssuedForCash`	$400.00K	USD	2 Qtrs
Stock issued for cash	`StockIssuedDuringPeriodValueIssuedForCash`	$50.98K	USD	2 Qtrs
Stock issued for cash	`StockIssuedDuringPeriodValueIssuedForCash`	$20.00K	USD	2 Qtrs
Receipt of subscription receivable	`StockholdersEquityOther`	$575.00	USD	Annual
Net loss	`NetIncomeLoss`	$-22.48K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-49.80K	USD	Annual
Net loss	`NetIncomeLoss`	$-1.08M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-18.71K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-5.67K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.45K	USD	Annual
Net loss	`NetIncomeLoss`	$-45.36K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.21M	USD	12 Qtrs
Balance	`StockholdersEquity`	$-41.19K	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.75K	USD	Point-in-time
Balance	`StockholdersEquity`	$333.45K	USD	Point-in-time
Balance	`StockholdersEquity`	$47.48K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.